Research Institute of Experimental Medicine, Department of Pathophysiology, Kursk State Medical University, 305041 Kursk, Russia.
Department of Chemical Carcinogenesis, N.N. Blokhin National Medical Research Center of Oncology, 115478 Moscow, Russia.
Int J Mol Sci. 2023 Dec 15;24(24):17537. doi: 10.3390/ijms242417537.
This review is focused on synephrine, the principal phytochemical found in bitter orange and other medicinal plants and widely used as a dietary supplement for weight loss/body fat reduction. We examine different aspects of synephrine biology, delving into its established and potential molecular targets, as well as its mechanisms of action. We present an overview of the origin, chemical composition, receptors, and pharmacological properties of synephrine, including its anti-inflammatory and anti-cancer activity in various in vitro and animal models. Additionally, we conduct a comparative analysis of the molecular targets and effects of synephrine with those of its metabolite, selective glucocorticoid receptor agonist (SEGRA) Compound A (CpdA), which shares a similar chemical structure with synephrine. SEGRAs, including CpdA, have been extensively studied as glucocorticoid receptor activators that have a better benefit/risk profile than glucocorticoids due to their reduced adverse effects. We discuss the potential of synephrine usage as a template for the synthesis of new generation of non-steroidal SEGRAs. The review also provides insights into the safe pharmacological profile of synephrine.
这篇综述主要关注辛弗林,它是在苦橙和其他药用植物中发现的主要植物化学物质,被广泛用作减肥/减少体脂肪的膳食补充剂。我们检查了辛弗林生物学的不同方面,深入研究了其已确立和潜在的分子靶标,以及其作用机制。我们介绍了辛弗林的来源、化学组成、受体和药理学特性概述,包括其在各种体外和动物模型中的抗炎和抗癌活性。此外,我们对辛弗林及其代谢物、选择性糖皮质激素受体激动剂(SEGRA)化合物 A(CpdA)的分子靶标和作用进行了比较分析,CpdA 与辛弗林具有相似的化学结构。SEGRAs,包括 CpdA,已被广泛研究作为糖皮质激素受体激动剂,由于其不良反应减少,它们具有比糖皮质激素更好的益处/风险比。我们讨论了将辛弗林用作新一代非甾体 SEGRA 合成的模板的潜力。该综述还提供了对辛弗林安全药理学特性的深入了解。